4th Quarter - Report

AVENUE SOLUTIONS for MERCK & CO. INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization; Antibiotics/stewardship; Value of prescription drugs; Monitor opioids legislation; Monitor 2019 Labor HHS appropriations legislation for impact on cervical cancer testing; S. 3787, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2018

LobbyistCovered position, as disclosed
TRACY SPICER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3787 (115th)

Medicare/Medicaid MMM

Issues relating to the further development of antibiotics and antimicrobials for serious and unmet medical needs; Antibiotics/stewardship; Value of prescription drugs; S. 3787, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2018

LobbyistCovered position, as disclosed
TRACY SPICER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3787 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.